GPR65 and cancer: Our results shed light on the immunomodulatory role of GPR65 and suggest that therapeutic intervention aimed at inhibiting GPR65 could improve anti-tumour immunity through the action of several immune cell types, including T-cells, a population with demonstrated anti-cancer potential in the context of IO therapeutic interventions.